Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 62 pseudogene 1 (ANKRD62P1)
- Target
- ANKRD62P1
- Molecular classification
- Other (Pseudogene, non-coding RNA)
01
Overview
Ankyrin repeat domain 62 pseudogene 1 (ANKRD62P1) is a transcribed unprocessed pseudogene located in the human genome, recognized by its similarity to protein-coding ankyrin repeat domain genes[5]. It does not encode a functional protein but is expressed as a non-coding RNA, with notable transcription in neural cells[3]. As a pseudogene, it may participate in regulatory RNA networks, potentially affecting parental gene expression via RNA mechanisms such as acting as miRNA sponges or generating regulatory non-coding RNAs, roles broadly documented for some pseudogenes but not specifically confirmed for ANKRD62P1[2][3][6][7]. There is no evidence supporting direct interaction with drugs, biomarker utility, or function as a therapeutic target.
- Other names
- ANKRD62P1ankyrin repeat domain 62 pseudogene 1
02
Biological functions
Other (no known protein function; some evidence for RNA-level regulation in general pseudogenes)
03
Disease associations
Other (no direct evidence for ANKRD62P1 in disease; general pseudogene roles may include contribution to gene regulation in cancer or neural function[2][3])
Beyond the preview
Go deeper on Ankyrin repeat domain 62 pseudogene 1 (ANKRD62P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ankyrin repeat domain 62 pseudogene 1 (ANKRD62P1).